Active Pharmaceutical Ingredient Market Size, Share, Growth and Forecast 2018-2026

The latest market report published by Credence Research, Inc. the market for active pharmaceutical ingredient was valued at US$ 152.6 billion in 2017 and is expected to reach US$ 273.5 billion by 2026 for a CAGR of 6.7 percent between 2018 and 2026.

Market Insights

The global market for active pharmaceutical ingredient (API) has shown a successful growth over the forecast period from 2018 to 2026. The API is the active part of any drug that produces its reaction. Many times a drug may contain few APIs and the reaction to a specific drug will depend on the prescription of a dosage pattern that changes from individual to individual. For instance, combination treatments have different dynamic active ingredients to treat different side effects. TEVA Pharmaceuticals is one of the world’s leading manufacturers of APIs with a vast portfolio of around 300 API products on the global market. Dr. Reddy’s is also a leading producer of APIs using more than 60 APIs currently.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/active-pharmaceutical-ingredient-market

North America contributes maximum revenue share in the global market for active pharmaceutical ingredients due to rising chronic diseases, increased adoption of prescribed drugs, demand for specialty drugs & biologics, increased awareness, and increased R&D for new drug formulations and developments. In the current scenario, manufacturers in the U.S. and Europe regions are expanding their manufacturing capacity for APIs in developing countries, such as India and China, to cut costs. This has made noteworthy changes to the way in which these drugs are regulated, with more specific guidelines and regulations. For example, currently AstraZeneca Plc produces only 15% of its APIs in the U.S. However, plans are underway to end this small ratio and outsource all manufacturing assemblies on the Asia Pacific and Latin American markets. Increased healthcare spending is a global phenomenon that has directly benefited the market for generic APIs in developing countries in recent years due to high demand and ease of access.

However, the cost of enhancing the process outline, the higher cost of specialty API drugs and the strict approval regulations may act as a constraining factor for the overall development of the API market. Improvement of new inventive APIs and inorganic development through mergers and partnerships with smaller organizations will further support the API market in developing countries. Adoption of branded generic drugs and medications is growing exponentially in developing economies, such as India and China. In addition, reduced use of specialty drugs is expected to increase pharmaceutical spending around the world.

Increase in demand for advanced therapeutics for treatment of alarming diseases, rising prevalence for chronic diseases and lifestyle diseases globally along with increasing purchasing power, beneficiary schemes for reimbursement are various factors fueling the demand for active pharmaceutical ingredient market in near future.

Key Market Movements:

• Globally, the active pharmaceutical ingredient market expected to exhibit a profitable growth with a CAGR of 6.7% for the period from 2018 to 2026
• Based on the API type, the synthetic chemical segment shows lucrative growth with increasing applications in the therapeutic treatment procedures.
• The development of the worldwide active pharmaceutical ingredient is mainly contributed the high demand for innovative therapeutics, a rise in FDA approvals, for new molecules and drugs, and expansion of the manufacturing capacity in the overseas market.
• In addition, new technology assessment in API manufacturing along with the existence of top API manufacturers & sophisticated healthcare facilities in the developed nations is further going to spur revenue growth during the forecast period.
• Eastern Europe, Latin America, and the Asia Pacific to show promising opportunities and shows growing CAGR during the forecast period owing to rising manufacturing capacity for active pharmaceutical ingredient and dosage pattern for various treatment. Surging population & along with ease in availability of drugs and medications, and increasing healthcare spending in Russia, Brazil, India, China, and Japan may contribute to the growth of the market during the forecast period.
• Major players in this vertical are Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Sanofi, Boehringer Ingelheim, Novartis International AG, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., Inc. and AbbVie Inc., Lonza Group and others.

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59336

Table of Content

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
 1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Active Pharmaceutical Ingredient Market Portraiture
2.2. Global Active Pharmaceutical Ingredient Market, By API Type, 2017 (US$ Mn)
2.3. Global Active Pharmaceutical Ingredient Market, By Drug Type, 2017 (US$ Mn)
2.4. Global Active Pharmaceutical Ingredient Market, By Manufacturing Type, 2017 (US$ Mn)
 2.5. Global Active Pharmaceutical Ingredient Market, by Geography, 2017 Vs 2026 (Value %)

Chapter 3. Global Active Pharmaceutical Ingredient Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Active Pharmaceutical Ingredient Technologies: Future Trends
3.3. Current Scenario: Strategies Used for Shifting Manufacturing Plants Internationally
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2017
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape
 3.8.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Active Pharmaceutical Ingredient Market, by API Type, 2016 - 2026 (US$ Mn)
4.1. Overview
4.2. Synthetic Chemical API
 4.3. Biological API

Chapter 5. Global Active Pharmaceutical Ingredient Market, by Drug Type, 2016 - 2026 (US$ Mn)
5.1. Overview
5.2. Branded Drugs
5.3. Generic Drugs
 5.4. OTC Drugs

Chapter 6. Global Active Pharmaceutical Ingredient Market, By Manufacturing Type, 2016 - 2026 (US$)
6.1. Overview
6.2. Contract Manufacturers
 6.3. Captive Manufacturers

Chapter 7. Global Active Pharmaceutical Ingredient Market, by Geography, 2016 - 2026 (US$ Mn)
 .............

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59336

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com